The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) announces a request for information regarding facilities that stockpile N95 respirators and Level 3 and Level 4 protective surgical gowns.
NIOSH is seeking information about personal protective equipment (PPE) environmental storage conditions and inventory for federal, city, state, municipal, county and hospital system stockpiles.
Specifically, NIOSH wans to know:
1. What type of stockpile are you affiliated with (e.g., federal, state, county)?
2. Who are the end users of the stockpiled products (e.g., healthcare workers, public)?
3. What environmental controls are implemented for the stockpiled PPE? For example, does the stockpile employ controls against humidity, temperature, sunlight, dust, or chemical exposure?
4. Are N95 respirators and Level 3 and Level 4 protective surgical gowns monitored for deterioration?
5. Are PPE products rotated?
6. Is PPE purchased from resellers?
7. What types of environmental controls are available in the shipping environment?
8. What are the brands, models, and quantity of your stockpiled N95 respirator and Level 3 and Level 4 protective surgical gown inventory?
The information you provide will assist NIOSH in identifying important factors to focus a future research study. In this future research study, NIOSH plans to sample N95 respirators and Level 3 and Level 4 protective surgical gowns from stockpiles and test them against established performance standards. NIOSH seeks to determine if certain stockpile conditions impact PPE performance and whether the shelf life of stockpiled PPE can be extended based on laboratory testing data. The information you provide will help NIOSH ensure that the study findings are broadly applicable to U.S. stockpiles.
Electronic or written comments must be received by 11:59 p.m. ET on April 24, 2017.
Participants may submit comments, identified by CDC-2017-0024 and docket number NIOSH-297, by any of the following methods:
• Federal eRulemaking Portal: http://www.regulations.gov Follow the instructions for submitting comments.
• Mail: National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226-1998.
All information received in response to this notice must include the agency name and docket number [CDC-2017-0024; NIOSH-297]. All relevant comments received will be posted without change to http://www.regulations.gov, including any personal information provided.
Source: NIOSH
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.